• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒16型E6蛋白使p53失活,导致人类细胞中诱变作用增强。

p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells.

作者信息

Havre P A, Yuan J, Hedrick L, Cho K R, Glazer P M

机构信息

Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520-8040, USA.

出版信息

Cancer Res. 1995 Oct 1;55(19):4420-4.

PMID:7671255
Abstract

To study the pathways associated with genomic instability in cancer, we examined UV-induced and spontaneous mutagenesis in clonal cell lines expressing human papillomavirus (HPV) proteins, either high-risk (HPV16) E6 or E7 or low-risk (HPV11) E6, in comparison to the parental RKO cells, a colon carcinoma cell line expressing only normal p53. High-risk E6 and E7 bind and functionally inactivate tumor suppressor proteins p53 and Rb, respectively, and both disrupt the G1 arrest in response to DNA damage. Low-risk HPV E6 proteins bind p53 with much lower affinity than high-risk E6 and fail to mediate p53 degradation or to disrupt the G1 checkpoint. We found that cells expressing HPV16 E6 had reduced survival and increased mutagenesis at the hprt locus when treated with low doses of UV. However, this analysis was complicated by the unexpected observation of a very high background of spontaneous mutagenesis in the unirradiated cells expressing the HPV16 E6 gene. Fluctuation analysis revealed a 5-fold elevated mutation rate in the cells expressing HPV16 E6. HPV11 E6 conferred a 2-fold elevation in the mutation rate, but HPV16 E7 had no effect. The increased spontaneous mutagenesis, therefore, appeared to be mediated by p53 inactivation and to be independent of Rb (which acts downstream of p53 in the G1 arrest pathway following DNA damage). Taken together, these findings suggest that the effect of p53 inactivation on spontaneous mutagenesis is manifested at the level of DNA repair, recombination, or coupling of transcription with one of these processes instead of by an alteration in G1 arrest.

摘要

为了研究癌症中与基因组不稳定相关的途径,我们检测了表达人乳头瘤病毒(HPV)蛋白(高危型(HPV16)E6或E7或低危型(HPV11)E6)的克隆细胞系中的紫外线诱导突变和自发突变,并与亲本RKO细胞(一种仅表达正常p53的结肠癌细胞系)进行比较。高危型E6和E7分别结合并功能性失活肿瘤抑制蛋白p53和Rb,二者均破坏对DNA损伤的G1期阻滞。低危型HPV E6蛋白与p53的结合亲和力远低于高危型E6,且无法介导p53降解或破坏G1期检查点。我们发现,用低剂量紫外线处理时,表达HPV16 E6的细胞在hprt位点的存活率降低且突变增加。然而,这一分析因意外观察到表达HPV16 E6基因的未照射细胞中自发突变背景非常高而变得复杂。波动分析显示,表达HPV16 E6的细胞中突变率升高了5倍。HPV11 E6使突变率升高了2倍,但HPV16 E7没有影响。因此,自发突变增加似乎是由p53失活介导的,且与Rb无关(Rb在DNA损伤后的G1期阻滞途径中位于p53下游起作用)。综上所述,这些发现表明,p53失活对自发突变的影响表现在DNA修复、重组或转录与这些过程之一的偶联水平,而不是通过改变G1期阻滞来实现。

相似文献

1
p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells.人乳头瘤病毒16型E6蛋白使p53失活,导致人类细胞中诱变作用增强。
Cancer Res. 1995 Oct 1;55(19):4420-4.
2
Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.人乳头瘤病毒E6蛋白定向突变的功能后果:p53介导的细胞周期停滞的消除与体外p53结合及降解相关
Virology. 1995 Apr 1;208(1):111-20. doi: 10.1006/viro.1995.1134.
3
Induction of the p53-target gene GADD45 in HPV-positive cancer cells.人乳头瘤病毒(HPV)阳性癌细胞中p53靶基因GADD45的诱导
Oncogene. 1999 Apr 8;18(14):2381-6. doi: 10.1038/sj.onc.1202557.
4
HPV-16 E6 oncoprotein induces mutations via p53-dependent and -independent pathways.
Oncol Rep. 2000 Jul-Aug;7(4):707-12.
5
E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.人乳头瘤病毒16型阳性口咽癌细胞的E6和E7基因沉默与转化表型
J Natl Cancer Inst. 2009 Mar 18;101(6):412-23. doi: 10.1093/jnci/djp017. Epub 2009 Mar 10.
6
p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.人乳头瘤病毒E6癌基因对宫颈癌细胞的p53非依赖性生长调控
Oncogene. 1996 Sep 5;13(5):1027-35.
7
Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.BPV1 E2介导的对HPV16阳性宫颈癌细胞中E6/E7表达的抑制作用。
Gynecol Oncol. 2001 Feb;80(2):168-75. doi: 10.1006/gyno.2000.6053.
8
The early HPV16 proteins can regulate mRNA levels of cell cycle genes in human cervical carcinoma cells by p53-independent mechanisms.早期人乳头瘤病毒16型蛋白可通过不依赖p53的机制调节人宫颈癌细胞中细胞周期基因的mRNA水平。
Virology. 1998 Apr 25;244(1):97-107. doi: 10.1006/viro.1998.9086.
9
A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.单密码子突变可将人乳头瘤病毒16型(HPV16)E6癌蛋白转化为一种潜在的肿瘤抑制因子,该因子可诱导HPV阳性的人宫颈癌HeLa细胞发生p53依赖性衰老。
Oncogene. 2009 Feb 5;28(5):762-72. doi: 10.1038/onc.2008.422. Epub 2008 Nov 17.
10
p53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts.p53 依赖的信号传导维持 DNA 复制并增强 254 纳米紫外线照射的人成纤维细胞的克隆形成存活率。
Cancer Res. 1998 May 1;58(9):1993-2002.

引用本文的文献

1
Rational Design of Stapled Covalent Peptide Modifiers of Oncoprotein E6 from Human Papillomavirus.人乳头瘤病毒癌蛋白E6的订书钉共价肽修饰剂的合理设计
ACS Chem Biol. 2025 Mar 21;20(3):746-757. doi: 10.1021/acschembio.4c00878. Epub 2025 Mar 10.
2
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update.免疫治疗时代的头颈部癌症治疗:2023 年更新。
Drugs. 2023 Feb;83(3):217-248. doi: 10.1007/s40265-023-01835-2. Epub 2023 Jan 16.
3
Association between promoter methylation and gene expression of and in HPV-infected cervical cancer cells.
人乳头瘤病毒(HPV)感染的宫颈癌细胞中[具体基因名称1]和[具体基因名称2]的启动子甲基化与基因表达之间的关联
Biomed Rep. 2022 Jan;16(1):1. doi: 10.3892/br.2021.1484. Epub 2021 Nov 3.
4
Targeting HPV in gynaecological cancers - Current status, ongoing challenges and future directions.针对妇科癌症中的 HPV - 现状、当前挑战和未来方向。
Womens Health (Lond). 2020 Jan-Dec;16:1745506520961709. doi: 10.1177/1745506520961709.
5
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints.通过阻断细胞周期检查点来靶向治疗头颈部癌症中的 DNA 损伤反应。
Int J Radiat Biol. 2021;97(8):1121-1128. doi: 10.1080/09553002.2020.1730014. Epub 2020 Feb 25.
6
Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV Cancers.髓系细胞调控全身免疫抑制,从而影响 HPV 癌症免疫治疗的疗效。
Cancer Immunol Res. 2020 Jan;8(1):131-145. doi: 10.1158/2326-6066.CIR-19-0315. Epub 2019 Nov 26.
7
Ubiquinol-cytochrome C reductase core protein II promotes tumorigenesis by facilitating p53 degradation.泛醌细胞色素 C 还原酶核心蛋白 II 通过促进 p53 降解促进肿瘤发生。
EBioMedicine. 2019 Feb;40:92-105. doi: 10.1016/j.ebiom.2019.01.002. Epub 2019 Jan 20.
8
Effects of HPV16E6 transfection on the biological behavior of Eca109 and Eca9706 cells.人乳头瘤病毒16型E6基因转染对Eca109和Eca9706细胞生物学行为的影响。
Oncol Lett. 2018 Feb;15(2):1646-1654. doi: 10.3892/ol.2017.7469. Epub 2017 Nov 22.
9
Clinical impact of human papillomavirus in laryngeal squamous cell carcinoma: a retrospective study.人乳头瘤病毒在喉鳞状细胞癌中的临床影响:一项回顾性研究。
PeerJ. 2017 May 30;5:e3395. doi: 10.7717/peerj.3395. eCollection 2017.
10
Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment.肿瘤抑制因子p53在宿主免疫反应和肿瘤微环境中的免疫调节功能
Int J Mol Sci. 2016 Nov 19;17(11):1942. doi: 10.3390/ijms17111942.